Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Exp Gastroenterol. 2012;5:151-7. doi: 10.2147/CEG.S25416. Epub 2012 Sep 17.

Update on triple therapy for eradication of Helicobacter pylori: current status of the art.

Author information

  • 1Gastroenterology and Endoscopy Unit, Viterbo.

Abstract

With the rising prevalence of antimicrobial resistance, the treatment success of standard triple therapy has recently declined to unacceptable levels (ie, 80% or less). Following the failure of conventional triple therapy, novel eradication regimens have been developed including sequential therapy, concomitant quadruple therapy, hybrid (dual-concomitant) therapy, bismuth-containing quadruple therapy, and a therapy with administration of N-acetylcysteine before a culture-guided antibiotic regimen. This article reviews the literature published on Helicobacter pylori eradication in the last year, focusing on the development of alternative strategies for first-, second-, and third-line rescue therapy for the eradication of H. pylori.

KEYWORDS:

N-acetylcysteine; concomitant therapy; hybrid therapy; quadruple therapy; sequential therapy

PMID:
23028235
[PubMed]
PMCID:
PMC3449761
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Dove Medical Press Icon for PubMed Central
    Loading ...
    Write to the Help Desk